Search Results
Venetoclax-Obinutuzumab vs Chlorambucil-Obinutuzumab To Treat CLL
CLL14 trial: obinutuzumab + venetoclax vs obinutuzumab + chlorambucil
5-year follow-up results of CLL14: obinutuzumab + venetoclax vs obinutuzumab + chlorambucil in CLL
CLL14: Venetoclax plus obinutuzumab for CLL
GLOW: primary analysis of ibrutinib plus venetoclax versus obinutuzumab plus chlorambucil in CLL
Six-year update from CLL14: fixed-duration venetoclax + obinutuzumab for previously untreated CLL
Dr. Gerson on Venetoclax/Obinutuzumab Combination in CLL
6-year results of CLL14: venetoclax-obinutuzumab for previously untreated CLL
iLLUMINATE 4-year follow up: obinutuzumab w/ ibrutinib vs w/ chlorambucil
Venetoclax and obinutuzumab combination therapy for CLL
Ideal patient for Venetoclax/Obinutuzumab combination | Dr. Jeff Sharman | Oncology Brothers #2023
Ibrutinib + Venetoclax vs Chlorambucil + Obinutuzumab in CLL - Dr. Carsten Niemann ASH 2022
